These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2475051)
21. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo]. Zhang YT; Wang NQ; Li N; Liu T; Dong ZW Yao Xue Xue Bao; 1992; 27(5):325-30. PubMed ID: 1442051 [TBL] [Abstract][Full Text] [Related]
22. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells. Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793 [TBL] [Abstract][Full Text] [Related]
23. [Targeting therapy with adriamycin-monoclonal antibody (HAb18) conjugate in nude mice with human hepatocellular carcinoma xenografts]. Sui Y Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):397-400, 445. PubMed ID: 1330227 [TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity and DNA binding characteristics of dextran-conjugated doxorubicins. Yang M; Chan HL; Lam W; Fong WF Biochim Biophys Acta; 1998 May; 1380(3):329-35. PubMed ID: 9555082 [TBL] [Abstract][Full Text] [Related]
25. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
26. Clinical application of monoclonal antibody-drug conjugate to immunotargeting chemotherapy of bladder cancer. Li L; Zhang Y; Lin Q; Li C; He M Chin Med J (Engl); 1995 Oct; 108(10):764-8. PubMed ID: 8565663 [TBL] [Abstract][Full Text] [Related]
27. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719 [TBL] [Abstract][Full Text] [Related]
28. DNA-mediated transfer and cloning of a human multidrug-resistant gene of adriamycin-resistant myelogenous leukemia K562. Sugimoto Y; Tsuruo T Cancer Res; 1987 May; 47(10):2620-5. PubMed ID: 3032411 [TBL] [Abstract][Full Text] [Related]
29. [Reversal effect of Ys-96, a bisbenzylisoquinoline, on adriamycin or vincristine resistance in human cancer cells in vitro]. Ye Z; Sun A; Li C; Xue B; Wang Z; Tong Y; Feng H; Liang A; Wang J; Yang Q Zhongguo Zhong Yao Za Zhi; 1998 Jul; 23(7):427-8, inside back cover. PubMed ID: 11601355 [TBL] [Abstract][Full Text] [Related]
30. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Fojo AT; Whang-Peng J; Gottesman MM; Pastan I Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7661-5. PubMed ID: 3865187 [TBL] [Abstract][Full Text] [Related]
31. [Production of adriamycin covalent binding to monoclonal antibody OC-859 and its anti-tumor activities]. Zhang L Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):346-8, 387. PubMed ID: 1804604 [TBL] [Abstract][Full Text] [Related]
32. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin. Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991 [TBL] [Abstract][Full Text] [Related]
33. Combined modalities of resistance in etoposide-resistant human KB cell lines. Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393 [TBL] [Abstract][Full Text] [Related]
34. Synergism of energy starvation and dextran-conjugated doxorubicin in the killing of multidrug-resistant KB carcinoma cells. Lam W; Chan H; Yang M; Cheng S; Fong W Anticancer Drugs; 1999 Feb; 10(2):171-8. PubMed ID: 10211547 [TBL] [Abstract][Full Text] [Related]
36. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds. Ramakrishnan S; Bjorn MJ; Houston LL Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383 [TBL] [Abstract][Full Text] [Related]
37. Specific targeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice. Adler R; Hurwitz E; Wands JR; Sela M; Shouval D Hepatology; 1995 Nov; 22(5):1482-7. PubMed ID: 7590667 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Raso V; Ritz J; Basala M; Schlossman SF Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605 [TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain. Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]